Invention Grant
US08735369B2 Compositions and methods for inhibiting expression of a gene from the Ebola virus
有权
用于抑制基因从埃博拉病毒表达的组合物和方法
- Patent Title: Compositions and methods for inhibiting expression of a gene from the Ebola virus
- Patent Title (中): 用于抑制基因从埃博拉病毒表达的组合物和方法
-
Application No.: US13627508Application Date: 2012-09-26
-
Publication No.: US08735369B2Publication Date: 2014-05-27
- Inventor: Sina Bavari , Kelly Lyn Warfield , Pamela Tan , Anna Borodovsky , Tatiana Novobrantseva , Antonin de Fougerolles
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge US DC Washington
- Assignee: Alnylam Pharmaceuticals, Inc.,The United States of America, as represented by the Secretary of the Army
- Current Assignee: Alnylam Pharmaceuticals, Inc.,The United States of America, as represented by the Secretary of the Army
- Current Assignee Address: US MA Cambridge US DC Washington
- Agency: Fenwick & West LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/11 ; C07H21/02 ; C07H21/04
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
Public/Granted literature
- US20130225654A1 Compositions And Methods for Inhibiting Expression Of A Gene From the Ebola Virus Public/Granted day:2013-08-29
Information query
